Hans Geyer
Papers
1
Total Citations
7
H-Index
1
About
Hans Geyer is a leading figure in doping control and clinical toxicology, with a research focus on advancing analytical methods for detecting prohibited substances and biomarkers in human specimens. His major contributions include pioneering the use of dried blood spots (DBS) for anti-doping and serological testing, demonstrating that minimal-invasively collected DBS samples can reliably detect anti-SARS-CoV-2 antibodies, as shown in his highly cited 2021 study (7 citations). This work significantly expanded the utility of DBS beyond traditional applications, offering a practical, scalable solution for pandemic management and remote health monitoring. Geyer’s impact is further underscored by his role in developing robust, automated extraction techniques coupled with electrochemiluminescence immunoassays (ECLIA), enhancing sensitivity and reproducibility in field settings. His achievements have been instrumental in shaping modern anti-doping protocols, particularly in integrating alternative matrices like DBS for more accessible and ethical testing. With a career spanning decades at the forefront of analytical chemistry, Geyer’s research continues to influence both sports integrity and public health surveillance, making him a pivotal figure in translational bioanalysis.
Research Focus
Key Achievements
Top Papers
- 1